Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Anixa Biosciences Inc Director's Dealing 2004

Jul 1, 2004

34117_dirs_2004-07-01_45a211e5-31d2-46d1-91b5-02a4ce565358.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: COPYTELE INC (COPY)
CIK: 0000715446
Period of Report: 2004-06-29

Reporting Person: KRUSOS DENIS A (Director, Chief Executive Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2004-06-29 Common Stock A 100000 Acquired 7077600 Direct

Footnotes

F1: Award, pursuant to the Copytele, Inc. 2003 Share Incentive Plan.

F2: Amount of securities beneficially owned includes 2,299,310 shares held and 4,778,290 shares which Denis A. Krusos has the
right to acquire upon exercise of options granted pursuant to CopyTele, Inc. stock option plans.